Recent Quarter Total Invested
$2.02 B
Recent Quarter Institutional Ownership Percentage
94.27%
Total Invested of Last Quarter
$2.50 B
Ownership Percentage of Last Quarter
94.93%
Intellia Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 07/26/2024 | 11.60 M | $259.51 M | 5.52% | 12.14% |
| BLACKROCK INC. | 08/13/2024 | 9.60 M | $214.79 M | 5.36% | 10.05% |
| VANGUARD GROUP INC | 08/13/2024 | 9.10 M | $203.66 M | 0.07% | 9.53% |
| DEEP TRACK CAPITAL, LP | 08/14/2024 | 4.80 M | $107.42 M | 13.99% | 5.03% |
| STATE STREET CORP | 08/14/2024 | 4.36 M | $97.64 M | -5.11% | 4.57% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 07/19/2024 | 3.26 M | $72.91 M | -4.17% | 3.41% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 08/09/2024 | 3.26 M | $72.91 M | -4.17% | 3.41% |
| MORGAN STANLEY | 08/14/2024 | 2.34 M | $52.32 M | -11.61% | 2.45% |
| FEDERATED HERMES, INC. | 08/08/2024 | 2.30 M | $51.49 M | 19.24% | 2.41% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 2.29 M | $51.35 M | 12.21% | 2.40% |
| FMR LLC | 08/13/2024 | 2.23 M | $49.87 M | 1.00% | 2.33% |
| CASDIN CAPITAL, LLC | 08/14/2024 | 2.00 M | $44.76 M | 6.67% | 2.09% |
| CONTRARIUS INVESTMENT MANAGEMENT LTD | 08/13/2024 | 1.92 M | $42.87 M | 41.83% | 2.01% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 1.78 M | $39.90 M | 13.45% | 1.87% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 1.32 M | $29.65 M | 8.07% | 1.39% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 1.27 M | $28.35 M | 18.66% | 1.33% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 1.24 M | $27.86 M | -23.39% | 1.30% |
| ROKOS CAPITAL MANAGEMENT LLP | 08/14/2024 | 1.14 M | $25.51 M | -22.05% | 1.19% |
| CHEVY CHASE TRUST HOLDINGS, LLC | 07/22/2024 | 1.04 M | $23.33 M | -2.98% | 1.09% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 08/13/2024 | 1.03 M | $23.05 M | -0.06% | 1.08% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 865,631 | $19.37 M | 125.50% | 0.91% |
| NORTHERN TRUST CORP | 08/14/2024 | 835,351 | $18.70 M | -4.13% | 0.87% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 829,285 | $18.56 M | 34.94% | 0.87% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 789,831 | $17.68 M | 8.45% | 0.83% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 781,774 | $17.50 M | -81.22% | 0.82% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 769,917 | $17.23 M | 16.77% | 0.81% |
| CITADEL ADVISORS LLC | 08/14/2024 | 762,680 | $17.07 M | -14.38% | 0.80% |
| PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 744,032 | $16.65 M | -7.59% | 0.78% |
| JPMORGAN CHASE & CO | 08/12/2024 | 669,105 | $14.97 M | 23.20% | 0.70% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 647,734 | $14.50 M | 3.40% | 0.68% |
| DISCOVERY VALUE FUND | 08/13/2024 | 561,561 | $12.57 M | 0.00% | 0.59% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2024 | 512,309 | $11.47 M | 34.95% | 0.54% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 452,448 | $10.13 M | -43.13% | 0.47% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 443,503 | $9.93 M | 2.52% | 0.46% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 394,000 | $8.82 M | 56.35% | 0.41% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 364,306 | $8.15 M | 0.64% | 0.38% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 08/12/2024 | 355,325 | $7.95 M | -15.48% | 0.37% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 347,483 | $7.78 M | 84.34% | 0.36% |
| AMERICAN CENTURY COMPANIES INC | 08/07/2024 | 330,514 | $7.40 M | 23.80% | 0.35% |
| CAPITAL ADVISORS INC/OK | 07/31/2024 | 311,045 | $6.96 M | 3.46% | 0.33% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 296,900 | $6.64 M | 15.84% | 0.31% |
| TEMASEK HOLDINGS (PRIVATE) LTD | 08/14/2024 | 279,693 | $6.26 M | 0.00% | 0.29% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2024 | 275,000 | $6.15 M | 11.20% | 0.29% |
| UBS GROUP AG | 08/14/2024 | 255,551 | $5.72 M | -22.93% | 0.27% |
| PINNACLE ASSOCIATES LTD | 07/30/2024 | 251,078 | $5.62 M | -1.81% | 0.26% |
| JANE STREET GROUP, LLC | 08/15/2024 | 245,426 | $5.49 M | 161.56% | 0.26% |
| ABRDN PLC | 08/09/2024 | 243,044 | $5.44 M | 57.55% | 0.25% |
| NORGES BANK | 08/14/2024 | 240,415 | $5.38 M | 100.00% | 0.25% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2024 | 234,815 | $5.26 M | 100.00% | 0.25% |
| PDT PARTNERS, LLC | 08/15/2024 | 227,220 | $5.09 M | 1.91% | 0.24% |
Intellia Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of NTLA shares?
During the previous two years, 385 institutional investors and hedge funds held shares of Intellia Therapeutics, Inc.. The most heavily invested institutionals were:
ARK Investment Management LLC: 11.6 M
BlackRock Inc.: 9.6 M
VANGUARD GROUP INC: 9.1 M
Deep Track Capital, LP: 4.8 M
STATE STREET CORP: 4.36 M
Sumitomo Mitsui Trust Holdings, Inc.: 3.26 M
-
What percentage of Intellia Therapeutics, Inc. stock is owned by institutional investors?
94.27% of Intellia Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at NTLA ?
Institutional investors have bought a total of 95.29 M shares in the last 24 months. This purchase volume represents approximately $1.70 B in transactions.